NMS myth busting series (#1)
The post NMS myth busting series (#1) appeared first on Community Pharmacy England.
We’re coming to a town near you
Community Pharmacy England’s annual regional roadshow series returns in less than a month, kicking off with events in Yorkshire & the North East in the first week of June. The series of interactive evening sessions will bring local pharmacies together with the people negotiating on their behalf to talk openly about funding, the challenges facing [...]
The post We’re coming to a town near you appeared first on Community Pharmacy England.
MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd)
MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) Drug alert number: EL(26)A/23 Date issued: 11 May 2026 Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets. DMRC reference number: DMRC- 39394163 Marketing Authorisation Holder: Milpharm Limited Medicine Details Product name: [...]
The post MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) appeared first on Community Pharmacy England.
IT system selection survey
NHS IT teams want to learn how community pharmacy owners and decision makers decide which services IT system to use or move towards when system decisions are being made. The aim would be to help pharmacy owners choose pharmacy IT systems and services (e.g. a Pharmacy First IT solution) more easily, in a clearer and [...]
The post IT system selection survey appeared first on Community Pharmacy England.
MHRA Drug Safety Update: Finasteride and Dutasteride – updated safety warnings
The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise this risk. The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise this risk. The product [...]
The post MHRA Drug Safety Update: Finasteride and Dutasteride – updated safety warnings appeared first on Community Pharmacy England.
Recent Comments